1. Home
  2. NOA vs CRVS Comparison

NOA vs CRVS Comparison

Compare NOA & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOA
  • CRVS
  • Stock Information
  • Founded
  • NOA 1953
  • CRVS 2014
  • Country
  • NOA Canada
  • CRVS United States
  • Employees
  • NOA N/A
  • CRVS N/A
  • Industry
  • NOA Meat/Poultry/Fish
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NOA Consumer Staples
  • CRVS Health Care
  • Exchange
  • NOA Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • NOA 478.5M
  • CRVS 459.0M
  • IPO Year
  • NOA 2006
  • CRVS 2016
  • Fundamental
  • Price
  • NOA $15.20
  • CRVS $7.59
  • Analyst Decision
  • NOA
  • CRVS Strong Buy
  • Analyst Count
  • NOA 0
  • CRVS 4
  • Target Price
  • NOA N/A
  • CRVS $13.75
  • AVG Volume (30 Days)
  • NOA 111.0K
  • CRVS 1.0M
  • Earning Date
  • NOA 11-12-2025
  • CRVS 11-04-2025
  • Dividend Yield
  • NOA 2.26%
  • CRVS N/A
  • EPS Growth
  • NOA N/A
  • CRVS N/A
  • EPS
  • NOA 0.87
  • CRVS N/A
  • Revenue
  • NOA $919,386,154.00
  • CRVS N/A
  • Revenue This Year
  • NOA $12.11
  • CRVS N/A
  • Revenue Next Year
  • NOA $6.35
  • CRVS N/A
  • P/E Ratio
  • NOA $17.39
  • CRVS N/A
  • Revenue Growth
  • NOA 14.15
  • CRVS N/A
  • 52 Week Low
  • NOA $12.12
  • CRVS $2.54
  • 52 Week High
  • NOA $22.08
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • NOA 59.60
  • CRVS 58.78
  • Support Level
  • NOA $15.13
  • CRVS $6.81
  • Resistance Level
  • NOA $15.69
  • CRVS $7.96
  • Average True Range (ATR)
  • NOA 0.46
  • CRVS 0.52
  • MACD
  • NOA 0.10
  • CRVS -0.03
  • Stochastic Oscillator
  • NOA 78.51
  • CRVS 67.50

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: